These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25914800)

  • 21. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
    Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
    Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX12: a novel potential target for acute myeloid leukaemia.
    Wan H; Cai J; Chen F; Zhu J; Zhong J; Zhong H
    Br J Haematol; 2017 Feb; 176(3):421-430. PubMed ID: 27858992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
    Lewis NR; Pallis M; Russell NH
    Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
    Aljedai A; Buckle AM; Hiwarkar P; Syed F
    PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.
    Martín-Henao GA; Quiroga R; Sureda A; García J
    Am J Hematol; 1999 Jul; 61(3):178-86. PubMed ID: 10398310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA profile of acute myeloid leukaemia indicates circular RNA annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukaemia.
    Ding Y; Dong Y; Lu H; Luo X; Fu J; Xiu B; Liang A; Zhang W
    Am J Transl Res; 2020; 12(5):1683-1699. PubMed ID: 32509169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
    Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
    Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.
    Alikian M; Gale RP; Apperley JF; Foroni L
    Biomol Detect Quantif; 2017 Mar; 11():4-20. PubMed ID: 28331814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bioinformatics Analysis and Verification of Aging-Related Genes of Bone Marrow Mesenchymal Stem Cells in Patients with Acute Myeloid Leukemia].
    Liu SQ; Cheng JY; Jiang YJ; Li Y; Li QH; Pang TX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):311-317. PubMed ID: 30998131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Screening and expression of CD34(+) cell-specific microRNA in acute myelogenous leukemia].
    Wang GP; Zhang SQ; Zhu P; Peng MY; Tan SQ; Yin H; Xu YJ; Chen Y; Chen FP
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):541-5. PubMed ID: 22967414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling in acute myeloid leukaemia (AML).
    Bacher U; Kohlmann A; Haferlach C; Haferlach T
    Best Pract Res Clin Haematol; 2009 Jun; 22(2):169-80. PubMed ID: 19698926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
    Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
    Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divergent effect of taxol on proliferation, apoptosis and nitric oxide production in MHH225 CD34 positive and U937 CD34 negative human leukaemia cells.
    Al-alami O; Sammons J; Martin JH; Hassan HT
    Leuk Res; 1998 Oct; 22(10):939-45. PubMed ID: 9766754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells.
    Collin JF; Wells JW; Czepulkowski B; Lyne L; Duriez PJ; Banham AH; Mufti GJ; Guinn BA
    Genes Chromosomes Cancer; 2015 May; 54(5):288-302. PubMed ID: 25706801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo expansion and characterisation of CD34+ cells derived from chronic myeloid leukaemia bone marrow and peripheral blood, and from normal bone marrow and mobilised peripheral blood.
    Garin MI; Apperley JF; Melo JV
    Eur J Haematol; 2000 Feb; 64(2):85-92. PubMed ID: 10997328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(A) cDNA real-time PCR for indicator gene measurement in cancer.
    Oliveira-Cunha M; Siriwardena AK; Byers RJ
    Methods Mol Biol; 2010; 630():13-32. PubMed ID: 20300988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemopoietic defect and decreased expansion potential of bone marrow autografts from patients with acute myeloid leukaemia in first remission.
    Straetmans N; Herman P; Van Bockstaele DR; Michaux L; Hagemeijer A; Ferrant A
    Br J Haematol; 1998 Jun; 101(3):571-81. PubMed ID: 9633904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.